MD Pediatrix Medical Group, Inc.
Stock · NYSE · United States · Healthcare · US58502B1061
NowoTrade is an independent information site. It is not affiliated with, endorsed by or sponsored by Pediatrix Medical Group, Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD.
Updated 07 Nov 2026 10:07. Information, not advice.
Results
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 18 Feb 2027 08:00 | 0.63 | — | — | Upcoming |
| 29 Oct 2026 06:00 | 0.65 | 0.72 | +10.8% | Beat |
| 04 Aug 2026 06:00 | 0.59 | 0.63 | +6.6% | Beat |
| 05 May 2026 06:00 | 0.38 | 0.44 | +16.1% | Beat |
| 19 Feb 2026 06:00 | 0.54 | 0.50 | -7.1% | Miss |
| 03 Nov 2025 06:00 | 0.47 | 0.67 | +43.9% | Beat |
| 05 Aug 2025 06:00 | 0.42 | 0.53 | +24.9% | Beat |
| 06 May 2025 06:00 | 0.24 | 0.33 | +36.7% | Beat |
| 20 Feb 2025 06:00 | 0.36 | 0.51 | +39.9% | Beat |
| 01 Nov 2024 06:00 | 0.37 | 0.44 | +19.7% | Beat |
| 06 Aug 2024 06:00 | 0.31 | 0.34 | +11.1% | Beat |
| 07 May 2024 06:00 | 0.19 | 0.20 | +5.9% | Beat |
| 20 Feb 2024 06:00 | 0.32 | 0.32 | -1.4% | Miss |
| 02 Nov 2023 07:00 | 0.43 | 0.32 | -26.0% | Miss |
| 03 Aug 2023 06:00 | 0.40 | 0.39 | -3.1% | Miss |
| 02 May 2023 06:00 | 0.22 | 0.23 | +3.8% | Beat |
| 17 Feb 2023 06:00 | 0.49 | 0.47 | -4.2% | Miss |
| 03 Nov 2022 06:00 | 0.54 | 0.40 | -26.3% | Miss |
| 04 Aug 2022 06:00 | 0.47 | 0.47 | -0.5% | In line |
| 28 Apr 2022 06:00 | 0.27 | 0.33 | +20.9% | Beat |
| 17 Feb 2022 06:00 | 0.43 | 0.52 | +22.0% | Beat |
| 28 Oct 2021 06:00 | 0.41 | 0.46 | +11.6% | Beat |
| 06 Aug 2021 06:00 | 0.32 | 0.41 | +27.2% | Beat |
| 07 May 2021 06:00 | 0.14 | 0.24 | +76.3% | Beat |
| 18 Feb 2021 06:00 | 0.36 | 0.25 | -30.2% | Miss |
| 06 Nov 2020 06:00 | 0.40 | 0.37 | -6.5% | Miss |
| 30 Jul 2020 06:00 | 0.12 | 0.32 | +167.1% | Beat |
| 07 May 2020 07:00 | 0.54 | 0.32 | -40.7% | Miss |
| 20 Feb 2020 06:00 | 0.90 | 0.91 | +1.0% | Beat |
| 01 Nov 2019 06:00 | 0.91 | 0.91 | +0.2% | In line |
| 01 Aug 2019 06:00 | 0.86 | 0.89 | +3.2% | Beat |
| 02 May 2019 06:00 | 0.71 | 0.71 | +0.4% | In line |
| 07 Feb 2019 06:00 | 0.91 | 0.92 | +1.5% | Beat |
| 01 Nov 2018 06:00 | 0.97 | 0.94 | -3.2% | Miss |
| 02 Aug 2018 06:00 | 1.07 | 1.07 | +0.3% | In line |
| 30 Apr 2018 18:00 | 0.86 | 0.89 | +3.1% | Beat |
| 08 Feb 2018 06:00 | 0.83 | 0.87 | +4.5% | Beat |
| 01 Nov 2017 06:00 | 0.84 | 0.87 | +3.0% | Beat |
| 28 Jul 2017 06:00 | 0.87 | 0.85 | -2.6% | Miss |
| 04 May 2017 06:00 | 0.75 | 0.75 | 0.0% | In line |
| 07 Feb 2017 06:00 | 1.06 | 1.00 | -5.3% | Miss |
| 27 Oct 2016 06:00 | 1.11 | 1.09 | -1.5% | Miss |
| 28 Jul 2016 06:00 | 1.07 | 1.03 | -3.6% | Miss |
| 28 Apr 2016 06:00 | 0.87 | 0.87 | -0.2% | In line |
| 04 Feb 2016 06:00 | 1.12 | 1.13 | +1.3% | Beat |
| 29 Oct 2015 06:00 | 1.07 | 1.10 | +2.7% | Beat |
| 30 Jul 2015 06:00 | 0.88 | 0.90 | +1.9% | Beat |
| 30 Apr 2015 06:00 | 0.71 | 0.72 | +1.8% | Beat |
| 29 Jan 2015 06:00 | 0.86 | 0.89 | +3.3% | Beat |
| 30 Oct 2014 06:00 | 0.85 | 0.86 | +1.1% | Beat |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 1.9B | -4.9% | 165.4M | 8.6% | 1.94 | +263.0% | 252.6M |
| 2024 | 2B | +0.9% | -99.1M | -4.9% | -1.19 | -63.0% | 184.6M |
| 2023 | 2B | +1.1% | -60.4M | -3.0% | -0.73 | -192.4% | 104M |
| 2022 | 2B | — | 66.3M | 3.4% | 0.79 | — | 137.2M |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| Oct 2024 | 11.48 | 13.02 | 11.40 | 12.32 | +6.30% | 13,000,800 | |
| Sep 2024 | 10.67 | 11.77 | 10.06 | 11.59 | +6.72% | 12,181,100 | |
| Aug 2024 | 8.33 | 11.50 | 7.47 | 10.86 | +30.22% | 14,860,400 | |
| Jul 2024 | 7.53 | 8.74 | 6.62 | 8.34 | +10.46% | 14,703,100 | |
| Jun 2024 | 7.40 | 8.32 | 6.70 | 7.55 | +3.28% | 39,066,600 | |
| May 2024 | 8.83 | 10.02 | 7.12 | 7.31 | -17.59% | 24,287,500 | |
| Apr 2024 | 10.09 | 10.12 | 8.74 | 8.87 | -11.57% | 13,013,800 | |
| Mar 2024 | 9.07 | 10.18 | 8.55 | 10.03 | +9.62% | 15,362,700 | |
| Feb 2024 | 9.34 | 9.61 | 7.70 | 9.15 | -2.24% | 14,415,400 | |
| Jan 2024 | 9.28 | 10.07 | 9.09 | 9.36 | +0.65% | 14,466,200 | |
| Dec 2023 | 8.33 | 9.85 | 8.18 | 9.30 | +10.98% | 19,517,700 | |
| Nov 2023 | 11.41 | 11.41 | 8.22 | 8.38 | -26.88% | 14,644,000 | |
| Oct 2023 | 12.67 | 13.01 | 11.09 | 11.46 | -9.83% | 9,311,800 | |
| Sep 2023 | 14.20 | 14.33 | 12.23 | 12.71 | -10.05% | 12,486,900 | |
| Aug 2023 | 13.69 | 15.02 | 13.38 | 14.13 | +2.91% | 8,067,700 | |
| Jul 2023 | 14.00 | 14.49 | 13.15 | 13.73 | -3.38% | 6,325,000 | |
| Jun 2023 | 13.34 | 14.43 | 13.30 | 14.21 | +6.84% | 14,249,700 | |
| May 2023 | 14.26 | 15.06 | 12.84 | 13.30 | -7.19% | 11,540,900 | |
| Apr 2023 | 14.94 | 15.20 | 13.59 | 14.33 | -3.89% | 10,734,400 | |
| Mar 2023 | 15.59 | 16.01 | 13.66 | 14.91 | -5.27% | 18,370,200 | |
| Feb 2023 | 15.33 | 17.30 | 14.44 | 15.74 | +2.54% | 15,467,500 | |
| Jan 2023 | 15.00 | 16.45 | 14.52 | 15.35 | +3.30% | 14,488,200 | |
| Dec 2022 | 16.01 | 16.32 | 14.40 | 14.86 | -7.01% | 10,562,500 | |
| Nov 2022 | 19.47 | 19.63 | 14.48 | 15.98 | -17.63% | 11,244,400 | |
| Oct 2022 | 16.62 | 19.63 | 16.14 | 19.40 | +17.50% | 8,191,000 |
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- Pediatrix Medical Group (MD) Upgraded to Buy: Here's What You Should Know (opens in a new tab) Zacks · 06 Nov 2026 16:00
- Pediatrix Medical Group Consensus Price Target Increased by 10.13% to $29.58 (opens in a new tab) Fintel · 02 Nov 2026 01:31
- Pediatrix Medical Group (MD) Q3 Results Leave Margin Pressure In Focus (opens in a new tab) Simply Wall St. · 31 Oct 2026 10:10
- Truist Securities Maintains Hold on Pediatrix Medical Group, Raises Price Target to $31 (opens in a new tab) Benzinga · 30 Oct 2026 12:51
- Pediatrix Medical Group, Inc. Q3 2026 Earnings Call Summary (opens in a new tab) Moby · 30 Oct 2026 12:30
- What Pediatrix Medical Group (MD) Said on Its Q3 Earnings Call (opens in a new tab) MarketBeat · 30 Oct 2026 09:14
- Pediatrix (MD) Q3 2026 Earnings Call Transcript (opens in a new tab) Motley Fool · 29 Oct 2026 21:44
- Pediatrix Medical Group (NYSE:MD) beats Q3 2026 sales expectations (opens in a new tab) StockStory · 29 Oct 2026 10:48
- Pediatrix Medical Group (MD) Beats Q3 Earnings and Revenue Estimates (opens in a new tab) Zacks · 29 Oct 2026 10:45
- Pediatrix Medical Group: Q3 Earnings Snapshot (opens in a new tab) Associated Press · 29 Oct 2026 10:15
- Pediatrix Medical Group (MD) reports earnings tomorrow: what to expect (opens in a new tab) StockStory · 28 Oct 2026 07:26
- Pediatrix Medical Group (MD) Stock Looks Undervalued Despite Its 154% Run (opens in a new tab) Simply Wall St. · 23 Oct 2026 18:11
- 3 Reasons MD is Risky and 1 Stock to Buy Instead (opens in a new tab) StockStory · 14 Oct 2026 14:56
- Can Pediatrix Sustain Growth Despite Lower Patient Volumes? (opens in a new tab) Zacks · 22 Sep 2026 16:14
- Pediatrix Medical Group (MD) Could Be 2% Below Fair Value Following Its Pullback (opens in a new tab) Simply Wall St. · 21 Sep 2026 11:10
Headlines link to the original articles of the publishers shown; NowoTrade does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 31.84 USD
- Market cap
- 2.4B
- Exchange
- NYSE
- Country
- United States
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Currency
- USD
Dividends
No dividends on record.
Why this score
| Part of the score | Points | Why |
|---|---|---|
| Business growth Yearly growth of revenue and of earnings per share. | 12.5 / 25 |
|
| Quality Return on equity, net margin and how stable the margins are. | 11.1 / 25 |
|
| Financial strength Net debt against operating earnings, interest cover and free cash flow. | 18.4 / 20 |
|
| Valuation Free cash flow yield and the P/E against its sector. | 14.7 / 15 |
|
| Analysts How far the analysts' average target is from today's price. | 1.1 / 10 |
|
Growth profile: it pays no dividend, so it is scored on business growth, quality and financial strength. Based on 95% of the figures (grade A).
Warnings take points off and some cap the score. In your account the score also considers how the share fits your portfolio.
Figures
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| P/E (trailing) | 17.1× | Fair | 31.09× |
| P/E (forward) | 12.65× | Good | 14.98× |
| Price / book | 2.8× | Fair | 3.94× |
| Price / sales | 1.25× | Good | 3.37× |
| EV / EBITDA | 9.98× | Good | 12.96× |
| Free cash flow yield | 5.8% | Good | 2.6% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Gross margin | 26.1% | Fair | 59.2% |
| Operating margin | 14.2% | Fair | 7.4% |
| Net margin | 7.7% | Fair | 3.4% |
| Return on equity | 17.2% | Good | 5.7% |
| Return on assets | 6.9% | Fair | 3.6% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Revenue growth / year | -1% | Weak | 10.8% |
| EPS growth / year | 34.9% | Good | 10.2% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Debt / equity | 0.72× | Good | 0.46× |
| Net debt / EBITDA | 0.71× | Good | 1.5× |
| Interest cover | 6.43× | Fair | 3.26× |
| Current ratio | 1.28× | Fair | 2.35× |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Payout of earnings | 0% | Weak | 0% |
The reading follows general rules of thumb and each sector has its own norms: compare with the sector median when it is shown. Information, not advice.
Follow MD and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.